Table 2.
Comparison of patient characteristics between patients surviving and those expiring in the overall population.
| Death (n = 36) | Survivor (n = 96) | p-value | |
|---|---|---|---|
| Age (years, mean ± SD) | 73.06 ± 12.03 | 57.67 ± 13.54 | < 0.001 |
| Female (n, %) | 10 (27.8) | 26 (27.1) | 0.936 |
| LDH (U/L, mean ± SD) | 419.56 ± 178.38 | 383.10 ± 139.66 | 0.219 |
| Lactic acid (mg/dL, mean ± SD) | 2.40 ± 1.43 | 1.61 ± 0.56 | 0.002 |
| C-reactive protein (mg/dL, mean ± SD) | 13.93 ± 7.60 | 10.90 ± 5.82 | 0.035 |
| Procalcitonin (ng/mL, mean ± SD) | 2.15 ± 8.83 | 0.34 ± 0.65 | 0.227 |
| Ferritin (ng/mL, mean ± SD) | 1220.86 ± 813.77 | 1189.35 ± 1020.13 | 0.868 |
| Serum creatinine (mg/dL, mean ± SD) | 1.53 ± 1.68 | 1.19 ± 1.78 | 0.324 |
| Oxygen saturation (%, mean ± SD) | 85.58 ± 13.06 | 90.70 ± 5·45 | 0.028 |
| Body mass index (kg/m2, mean ± SD) | 30·33 ± 8·25 | 30.20 ± 5.70 | 0.934 |
| Ventilator use (n, %) | 22 (61.1) | 15 (15·6) | < 0.001 |
| Comorbidity index score (mean ± SD) | 2.39 ± 2.72 | 1.06 ± 1.76 | 0.009 |
| Hypertension (n, %) | 24 (66.7) | 48 (50.0) | 0.087 |
| Myocardial infarction (n, %) | 7 (19.4) | 6 (6.7) | 0.023 |
| Heart failure (n, %) | 5 (13.9) | 2 (2.1) | 0.016 |
| Cerebrovascular disease (n, %) | 6 (16.7) | 6 (6.3) | 0.064 |
| Peripheral vascular disease (n, %) | 3 (8.3) | 5 (5.2) | 0.683 |
| Dementia (n, %) | 6 (16.7) | 2 (2.1) | 0.005 |
| Chronic pulmonary disease (n, %) | 11 (30.6) | 9 (9.4) | 0.003 |
| Rheumatic disease (n, %) | 2 (5.6) | 2 (2.1) | 0.299 |
| Peptic ulcer disease (n, %) | 0 (0) | 3 (9.4) | 0.562 |
| Liver disease (n, %) | 1 (2.8) | 1 (1.0) | 0.473 |
| Diabetes (n, %) | 13 (33.3) | 28 (29.2) | 0.443 |
| Hemiplegia/paraplegia (n, %) | 1 (2.8) | 1 (1.0) | 0.473 |
| Renal disease (n, %) | 4 (11.1) | 3 (3.1) | 0.088 |
| Any malignancy (n, %) | 3 (8.3) | 0 (0) | 0.019 |
| Metastatic solid tumor (n, %) | 2 (5.6) | 3 (3.1) | 0.613 |